XVIVO PERFUSION AB (PUBL)

XVIVO PERFUSION AB (PUBL)

Xvivo Perfusion AB (publ), a medical technology company, develops solutions for organ, tissue, and cell preservation and perfusion in connection with transplantation. The company offers XVIVO Perfusion System (XPS), an integrated off-the-shelf cardiac bypass system that includes various components needed to safely run normothermic ex-vivo lung perfusion (EVLP); XPS Disposable Lung Kit that contains disposables and pre-packed products to suit requirement for sterility; and STEEN Solution, a buffe... red extracellular solution optimally designed to perfuse the isolated donor lung during EVLP. It also provides Perfadex, a buffered extracellular colloid-based electrolyte preservation solution; Perfadex Plus, an extracellular, low potassium, dextran-based electrolyte preservation solution; XVIVO Silicone Tubing Set for rapid flushing of donor lungs during procurement; and XVIVO LS and XVIVO Disposable Lung Set, a device for EVLP. In addition, the company offers XVIVO Organ Chamber, a single-use sterile disposable container intended to be used as a temporary receptacle for isolated lungs in preparation for eventual transplantation into a recipient; and XVIVO Lung Cannula Set, a single-use, sterile disposable product. Xvivo Perfusion AB (publ) was founded in 1998 and is headquartered in Gothenburg, Sweden.

Xvivo Perfusion Ab (publ)_logo

Industry:
Company

Address:
Box 53015, Gothenburg, Sweden Zipcode 400 14

Country:
Sweden

Phone:
46 3 17 88 21 50

Market Cap:
7.21B
Total Revenue:
179.86M
Total Assets:
1.15B
Total Cash:
354.24M

Subsidiary: Vivoline Medical AB


Key Executives
Name Title Pay Year Born
Dr. Magnus Nilsson Sr. Advisor N/A 1956(64 years old)
Mr. Dag Andersson Pres & CEO N/A 1961(59 years old)
Mr. Kristoffer Nordstrom Chief Financial Officer N/A N/A
Mr. Christoffer Rosenblad COO & Board Sec. N/A 1975(45 years old)
Mr. Andreas Wallinder M.D., Ph.D. Chief Medical Officer N/A 1977(43 years old)
Mr. Johan Holmstrom Chief Commercial Officer N/A 1970(50 years old)
Mr. Christer de Flon Mang. N/A 1949(71 years old)
Ms. Katrin Gisselfalt Quality & Regulatory Director N/A 1969(51 years old)



Financial & Stock
Exchange Stockholm. Currency in SEK. Market state PREPRE
According to Xvivo Perfusion Ab (publ)'s financial reports the company's revenue in 2020 were 179.86M an decrease(-18.64%) over the years 2019 revenue that were of 220.84M. In 2020 the company's total earnings were -43.73M while total earnings in 2019 were 4.94M(-1175%).
Company's stock symbol is XVIVO.ST. Lastest price : 271.00. Total volume :13.02k Click reload if you want to check the lastest price on market!!!


Site Inspections: http://www.xvivoperfusion.com

  • Host name: dedi96.aname.net
  • IP address: 89.221.240.190
  • Location: Sweden
  • Latitude: 59.3247
  • Longitude: 18.056
  • Timezone: Europe/Stockholm

Loading ...
Loading ...


More informations about "Xvivo Perfusion Ab (publ)" on Search Engine

Xvivo Perfusion AB (publ) (XVIPF) - Yahoo

Finance.yahoo.com Xvivo Perfusion AB (publ), a medical technology company, develops solutions for organ, tissue, and cell preservation and perfusion in connection with transplantation.

XVIVO Perfusion | 2021 - XVIVO Perfusion

Xvivoperfusion.com Kallelse till årsstämma i XVIVO Perfusion AB (publ) 2021-02-26 16:30. News. IR. English. Corporate Information. Other Corporate Information. Publication in The New England Journal of Medicine shows complications after liver transplantation significantly reduced with cold, oxygenated machine perfusion. 2021-02-26 16:30.

XVIVO PERFUSION AB (PUBL)

Xvivoperfusion.com XVIVO PERFUSION AB (PUBL) XVIVO Perfusion is a medical technology company which develops and markets solutions and systems for assessing the usability of organs, enabling the treatment of organs, and maintaining organs in good condition outside of the body, pending transplantation.

XVIVO PERFUSION AB (PUBL) : Shareholders Board Members

Marketscreener.com Xvivo Perfusion AB is a Sweden-based medical technology company focused on developing optimized solutions for organ, tissue and cell preservation in connection with transplantation. The Company operates in two segments: Durable goods and Non-Durable goods.

NOTICE TO ATTEND THE ANNUAL GENERAL MEETING IN …

Xvivoperfusion.com The completed voting form must be submitted to XVIVO no later than Wednesday 21 April 2021. The completed and signed form shall be sent to XVIVO Perfusion AB (publ), 2021, c/o AGM Advokatfirman Vinge KB, Box 110 25, 404 21 GothenburSE- g, Sweden. A completed form may also be submitted by e -mail and is to be sent to . [email protected]

Nomination committee of XVIVO Perfusion AB (publ) - XVIVO

Xvivoperfusion.com Martin Lewin, appointed by Eccenovo AB Gösta Johannesson, chairman of the board of directors. The appointments have been made in accordance with the instructions regarding principles for the appointment of the company’s nomination committee which were established by the annual general meeting of XVIVO Perfusion AB (publ) on April 27, 2018.

How Much Of Xvivo Perfusion AB (publ) (STO:XVIVO) Do

Simplywall.st OM:XVIVO Earnings and Revenue Growth November 17th 2020. Hedge funds don't have many shares in Xvivo Perfusion. Bure Equity AB (publ) is currently the company's largest shareholder with 15% of shares outstanding. Meanwhile, the second and third largest shareholders, hold 5.9% and 5.7%, of the shares outstanding, respectively.

Calculating The Intrinsic Value Of Xvivo Perfusion AB

Simplywall.st How far off is Xvivo Perfusion AB (publ) from its intrinsic value? Using the most recent financial data, we'll take a look at whether the stock is fairly priced by estimating the company's future cash flows and discounting them to their present value. We will take advantage of the Discounted Cash Flow (DCF) model for this purpose.

Have Insiders Been Buying Xvivo Perfusion AB (publ) (STO)

Simplywall.st So we'll take a look at whether insiders have been buying or selling shares in Xvivo Perfusion AB (publ) . Do Insider Transactions Matter? It is perfectly legal for company insiders, including board members, to buy and sell stock in a company. However, such insiders must disclose their trading activities, and not trade on inside information.

Xvivo Perfusion AB (publ) (XVIVO.ST) - Yahoo

Finance.yahoo.com Xvivo Perfusion AB (publ) was founded in 1998 and is headquartered in Gothenburg, Sweden. Corporate Governance. Xvivo Perfusion AB (publ)’s ISS Governance QualityScore as of N/A is N/A.

Xvivo Perfusion AB (via Public) / Notice to attend the

Publicnow.com XVIVO Perfusion is a medical device company that develops and markets solutions and systems for assessing usability, enabling treatment of organs and preserving organs in good condition outside the body while waiting for a transplantation. The company is active within all of the major organ areas; heart, lung, liver and kidney.

Xvivo Perfusion AB, XVIVO:STO summary - FT.com

Markets.ft.com Xvivo Perfusion AB is a Sweden-based medical technology company focused on developing optimized solutions for organ, tissue and cell preservation in connection with transplantation. The Company operates in two segments: Durab le goods and Non-Durable goods.

Need To Know: Xvivo Perfusion AB (publ) (STO:XVIVO)

Simplywall.st Need To Know: Xvivo Perfusion AB (publ) (STO:XVIVO) Insiders Have Been Buying Shares By Simply Wall St Published October 27, 2020. It is not uncommon to see companies perform well in the years after insiders buy shares. The flip side of that is that there are more than a few examples of insiders dumping stock prior to a period of weak performance.

Annual Report 2019 - Xvivo Perfusion

News.cision.com For further information on XVIVO Perfusion’s business, please refer to the company’s website, www.xvivoperfusion.com. This information is information that Xvivo Perfusion AB (publ) is obliged to make public pursuant to the Securities Markets Act. The information was submitted for publication on March 9, 2020 at 09:00 a.m.

Xvivo Perfusion

News.cision.com Xvivo Perfusion; US/UK/Canada . US/UK/Canada Sweden Share. Pick a time period -Search. Tags (Active) In the starting blocks for heart preservation and PrimECC trial Fri, Jul 10, 2020 07:30 CET. SECOND QUARTER 2020 (APRIL-JUNE) Financial information · Net sales of non-durable goods in the quarter amounted to SEK 28.0 (50.5) million ...

Xvivo Perfusion (OM:XVIVO) - Share price, News & Analysis

Simplywall.st Xvivo Perfusion AB (publ), a medical technology company, develops solutions for organ, tissue, and cell preservation and perfusion in connection with transplantation. More Details. Rewards. Trading at 18% below our estimate of its fair value. Earnings are forecast to grow 93.3% per year.

Should You Buy XVIVO.ST Stock?

Stockinvest.us The Xvivo Perfusion AB (publ) stock holds a buy signal from the short-term moving average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in …

XVIVO PERFUSION AB (PUBL) : XVIVO Stock Price

Marketscreener.com Xvivo Perfusion AB is a Sweden-based medical technology company focused on developing optimized solutions for organ, tissue and cell preservation in connection with transplantation. The Company operates in two segments: Durable goods and Non-Durable goods.

Xvivo Perfusion AB (publ) (XVIVO.ST) - Yahoo Finance

Sg.finance.yahoo.com Find the latest Xvivo Perfusion AB (XVIVO.ST) stock quote, history, news and other vital information to help you with your stock trading and investing.

Why Xvivo Perfusion AB (publ) (STO:XVIVO) Is An Attractive

Finance.yahoo.com Attractive stocks have exceptional fundamentals. In the case of Xvivo Perfusion AB (publ) (STO:XVIVO), there’s is a company with robust financial health as well as an optimistic future outlook.

Xvivo Perfusion AB (publ) (XVIPF) - Yahoo

Finance.yahoo.com Discover historical prices for XVIPF stock on Yahoo Finance. View daily, weekly or monthly format back to when XVIVO PERFUSION AB stock was issued.

XVIVO PERFUSION AB (PUBL) : Stock Market News and

Marketscreener.com The Board of Directors' of XVIVO Perfusion AB (publ) (the "Company" or "XVIVO") proposal that the annual general meeting resolve on (15A.) the adoption of a long-term incentive programme directed at senior executives and key individuals in the XVIVO group ("LTIP 2021 "), and (15B.) a directed issue of warrants (Series 2021/2024) to participants ...

Xvivo Perfusion : Notice to attend the Annual General

Marketscreener.com The executive management of XVIVO Perfusion AB (publ) ('XVIVO Perfusion') and the board of directors, insofar as remuneration other than that decided by the general meeting is paid to board members, fall within the provisions of these guidelines. The executive management includes the CEO, the deputy CEO and other members of the executive ...

Extraordinary General Meeting of Vitrolife AB (publ) 2012

Vitrolife.com Sep 24, 2012 · Report from the Extraordinary General Meeting of Vitrolife AB (publ) held on September 24, 2012 . The meeting adopted a resolution to distribute shares in the subsidiary Xvivo Perfusion AB to company shareholders, whereby one (1) existing share in Vitrolife AB entitles shareholders to distribution of one (1) share in Xvivo Perfusion AB.

MFN.se > XVIVO Perfusion AB > Nomination committee of

Mfn.se The annual general meeting of XVIVO Perfusion AB (publ) will be held on April 22, 2021 in Gothenburg. Shareholders who wish to submit proposals to the nomination committee are welcome to do so in due time before the annual general meeting 2021 so that the nomination committee has time to …

Villkor för XVIVO Perfusion AB (publ):s teckningsoptioner

Xvivoperfusion.com Villkor för XVIVO Perfusion AB (publ):s teckningsoptioner 2021 . Terms and Conditions for XVIVO Perfusion AB (publ)’s warrants 2021 . 1 Definitioner/ Definitions. I dessa villkor ska följande benämningar ha den innebörd som anges nedan. In these terms and conditions, the following terms shall have the meaning given below.

Report from Annual general meeting of XVIVO Perfusion AB

News.cision.com This information is information that Xvivo Perfusion AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 5:00 p.m. CET on March 31, 2020.

XVIVO PERFUSION AB (PUBL) : Stock Market News and

Marketscreener.com XVIVO PERFUSION AB (PUBL) : News, information and stories for XVIVO PERFUSION AB (PUBL) | Nasdaq Stockholm: XVIVO | Nasdaq Stockholm

XVIVO PERFUSION AB (PUBL) : Press releases | XVIVO

Marketscreener.com Communiqués de presse de la société XVIVO PERFUSION AB (PUBL) 02/17: XVIVO PERFUSION : First Belgian patient receives heart transplant with new pres..

Xvivo Perfusion AB (publ) (0RKL.L) - Yahoo

Sg.finance.yahoo.com Get the latest XVIVO PERFUSION AB XVIVO PERFUS (0RKL.L) stock news and headlines to help you in your trading and investment decisions.

Xvivo Perfusion AB (publ) (0RKL.L) - Yahoo

Sg.finance.yahoo.com See the company profile for XVIVO PERFUSION AB XVIVO PERFUS (0RKL.L), including business summary, industry/sector information, number of employees, corporate governance, key executives and salary information.

MarketScreener Homepage

Marketscreener.com XVIVO PERFUSION : Notice to attend the Annual General Meeting in XVIVO Perfusion AB (publ) AQ. 02/25: XVIVO PERFUSION ...

Xvivo Perfusion AB (publ) (0RKL) historie ceny akcie

Cs.wallmine.com Xvivo Perfusion AB (publ), a medical technology company, develops solutions for organ, tissue, and cell preservation and perfusion in connection with transplantation. The company offers XVIVO Perfusion System (XPS), an integrated off-the-shelf cardiac bypass system that includes various components needed to safely run normothermic ex-vivo lung perfusion (EVLP); XPS Disposable Lung Kit that ...

Shareholders Should Look Hard At Xvivo Perfusion AB (publ)

Simplywall.st Jan 29, 2020 · Today we'll look at Xvivo Perfusion AB (publ) and reflect on its potential as an investment.In particular, we'll consider its Return On Capital Employed (ROCE), as that can give us insight into how profitably the company is able to employ capital in its business.

Xvivo Perfusion AB (publ) (XVIVO.ST) - finance.yahoo.com

Finance.yahoo.com Discover historical prices for XVIVO.ST stock on Yahoo Finance. View daily, weekly or monthly format back to when Xvivo Perfusion AB stock was issued.

What Type Of Shareholders Own The Most Number of Xvivo

Simplywall.st OM:XVIVO Earnings and Revenue Growth February 26th 2021. We note that hedge funds don't have a meaningful investment in Xvivo Perfusion. The company's largest shareholder is Bure Equity AB (publ), with ownership of 15%.

Xvivo Perfusion AB (publ) (0RKL.L) - Yahoo

Uk.finance.yahoo.com Find the latest XVIVO PERFUSION AB XVIVO PERFUS (0RKL.L) stock quote, history, news and other vital information to help you with your stock trading and investing.

Xvivo Perfusion AB (publ) Just Missed Earnings And Its EPS

Finance.yahoo.com Last week, you might have seen that Xvivo Perfusion AB (publ) released its annual result to the market.The early response was not positive, with shares down 5.6% to kr175 in the past week. It ...

Results: Xvivo Perfusion AB (publ) Delivered A Surprise

Simplywall.st Jul 13, 2020 · Shareholders might have noticed that Xvivo Perfusion AB (publ) filed its quarterly result this time last week.The early response was not positive, with shares down 3.3% to kr176 in the past week. It was a pretty bad result overall, with revenues coming in 34% lower than the analysts predicted.

Xvivo Perfusion AB (publ) Just Missed Earnings And Its EPS

Ca.news.yahoo.com Last week, you might have seen that Xvivo Perfusion AB (publ) released its annual result to the market.The early response was not positive, with shares down 5.6% to kr175 in the past week. It looks like a pretty bad result, all things considered.

Historical XVIVO.ST stock prices (quote) - Xvivo Perfusion

Stockinvest.us Xvivo Perfusion AB (publ) Stock Price (Quote) OMX:XVIVO 274.00 kr (0.74% ) Wednesday, 31st Mar 2021 Range Low Price High Price Comment; 30 days: 264.50 kr: 334.00 kr: Wednesday, 31st Mar 2021 XVIVO.ST stock ended at 274.00 kr. This is 0.74% more than …

Xvivo Perfusion AB (publ) (XVIPF) Stock Price Today, Quote

Seekingalpha.com Xvivo Perfusion AB (publ), a medical technology company, develops solutions for organ, tissue, and cell preservation and perfusion in connection with transplantation.

XVIVO opens a subsidiary in Australia - Xvivo Perfusion

News.cision.com XVIVO opens a subsidiary in Australia Wed, Oct 23, 2019 16:00 CET. Based on the increasing interest for XVIVO Perfusion´s products for lung transplantation as well as the high interest from all Australian clinics to participate in the Heart preservation study XVIVO Perfusion AB (publ) has decided to open a subsidiary in Sydney, Australia.

Annual General Meeting of XVIVO Perfusion AB (publ)

News.cision.com Annual General Meeting of XVIVO Perfusion AB (publ) Wed, Mar 20, 2019 09:00 CET. The shareholders of XVIVO Perfusion AB (publ), corporate identity number 556561-0424 (“the Company”), are hereby invited to attend the Annual General Meeting of shareholders on Thursday April 25, 2019 at 15.00 at World Trade Center (Floor 7, one floor below the Company’s premises), Mässans gata 10 in ...

Xvivo Perfusion AB (publ) (XVIPF) - Yahoo Finance

Finance.yahoo.com Interactive Chart for XVIVO PERFUSION AB (XVIPF), analyze all the data with a huge range of indicators.

Xvivo Perfusion AB (publ) (0RKL.L) - Yahoo

Nz.finance.yahoo.com See the company profile for XVIVO PERFUSION AB XVIVO PERFUS (0RKL.L), including business summary, industry/sector information, number of employees, corporate governance, key executives and salary information.